Salona Global Focuses on US Capital Markets for 2023; Changes Fiscal Year End to December 31, 2022 to Prepare for US Listing; Withdraws Canadian Debenture Offering

SAN DIEGO, Dec. 15, 2022 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (“Salona Global”, “SGMD”, or the “Company”) (TSXV:SGMD) announced today its intention to focus on listing on the Nasdaq Capital Market (“Nasdaq”) in 2023. As a first step, Salona Global has changed its fiscal year end to December 31, 2022 with the aim of preparing for a U.S. listing, and has withdrawn the recently announced debenture offering in Canada. Salona will move forward with the process of closing the recently announced acquisition of assets of Biodex Medical Systems, Inc. without participation from the Canadian capital markets.

Read more at globenewswire.com